Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15395 | 715 | 32.8 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
389 | 3 | PEROXISOME//CARNITINE//JOURNAL OF INHERITED METABOLIC DISEASE | 30841 |
1504 | 2 | CARNITINE//L CARNITINE//TRIMETAZIDINE | 7543 |
15395 | 1 | TRIMETAZIDINE//PERHEXILINE//TRIMETAZIDINE MB | 715 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRIMETAZIDINE | authKW | 9042191 | 39% | 76% | 278 |
2 | PERHEXILINE | authKW | 1612985 | 7% | 79% | 48 |
3 | TRIMETAZIDINE MB | authKW | 298938 | 1% | 100% | 7 |
4 | TRIMETASIDINE | authKW | 170822 | 1% | 100% | 4 |
5 | HYDROXYPERHEXILINE | authKW | 128116 | 0% | 100% | 3 |
6 | UNITE TRANSPLANTAT EXPT | address | 124224 | 1% | 36% | 8 |
7 | TRIMETAZIDINE MR | authKW | 96086 | 0% | 75% | 3 |
8 | TRIMETAZIDINE TMZ | authKW | 96086 | 0% | 75% | 3 |
9 | UNITE CHIRURG HEPAT | address | 96086 | 0% | 75% | 3 |
10 | ANTI ANGINAL AGENTS | authKW | 85411 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 7962 | 42% | 0% | 297 |
2 | Pharmacology & Pharmacy | 2305 | 34% | 0% | 244 |
3 | Medicine, General & Internal | 377 | 12% | 0% | 86 |
4 | Peripheral Vascular Diseases | 125 | 5% | 0% | 33 |
5 | Medicine, Research & Experimental | 82 | 5% | 0% | 37 |
6 | Chemistry, Analytical | 64 | 6% | 0% | 40 |
7 | Medical Laboratory Technology | 63 | 2% | 0% | 13 |
8 | Toxicology | 36 | 3% | 0% | 21 |
9 | Transplantation | 16 | 1% | 0% | 10 |
10 | Biochemical Research Methods | 15 | 3% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITE TRANSPLANTAT EXPT | 124224 | 1% | 36% | 8 |
2 | UNITE CHIRURG HEPAT | 96086 | 0% | 75% | 3 |
3 | CARDIOL CLIN PHARMACOL | 60723 | 1% | 18% | 8 |
4 | HEPAT I EMIA REPERFUS UNIT | 56939 | 0% | 67% | 2 |
5 | UR1154 | 56939 | 0% | 67% | 2 |
6 | VASC DIS THER EUT GRP | 56939 | 0% | 67% | 2 |
7 | CLIN CARDIOL HEART FAILURE UNIT | 54904 | 0% | 43% | 3 |
8 | EA 2426 | 48040 | 0% | 38% | 3 |
9 | UMR 1154 | 45208 | 1% | 18% | 6 |
10 | ADV CHON DIS | 42705 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASCULAR DRUGS AND THERAPY | 16044 | 4% | 1% | 27 |
2 | CARDIOVASCULAR THERAPY AND PREVENTION | 14643 | 2% | 2% | 16 |
3 | KARDIOLOGIYA | 10430 | 6% | 1% | 40 |
4 | RUSSIAN JOURNAL OF CARDIOLOGY | 9086 | 1% | 2% | 10 |
5 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 7009 | 2% | 1% | 13 |
6 | ARCHIVES OF MEDICAL SCIENCE | 2979 | 1% | 1% | 10 |
7 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2526 | 2% | 1% | 11 |
8 | CORONARY ARTERY DISEASE | 2412 | 2% | 0% | 12 |
9 | TERAPEVTICHESKII ARKHIV | 2138 | 3% | 0% | 20 |
10 | CLINICAL TRIALS AND META-ANALYSIS | 1523 | 0% | 4% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRIMETAZIDINE | 9042191 | 39% | 76% | 278 | Search TRIMETAZIDINE | Search TRIMETAZIDINE |
2 | PERHEXILINE | 1612985 | 7% | 79% | 48 | Search PERHEXILINE | Search PERHEXILINE |
3 | TRIMETAZIDINE MB | 298938 | 1% | 100% | 7 | Search TRIMETAZIDINE+MB | Search TRIMETAZIDINE+MB |
4 | TRIMETASIDINE | 170822 | 1% | 100% | 4 | Search TRIMETASIDINE | Search TRIMETASIDINE |
5 | HYDROXYPERHEXILINE | 128116 | 0% | 100% | 3 | Search HYDROXYPERHEXILINE | Search HYDROXYPERHEXILINE |
6 | TRIMETAZIDINE MR | 96086 | 0% | 75% | 3 | Search TRIMETAZIDINE+MR | Search TRIMETAZIDINE+MR |
7 | TRIMETAZIDINE TMZ | 96086 | 0% | 75% | 3 | Search TRIMETAZIDINE+TMZ | Search TRIMETAZIDINE+TMZ |
8 | ANTI ANGINAL AGENTS | 85411 | 0% | 100% | 2 | Search ANTI+ANGINAL+AGENTS | Search ANTI+ANGINAL+AGENTS |
9 | CAS13171 25 0 | 85411 | 0% | 100% | 2 | Search CAS13171+25+0 | Search CAS13171+25+0 |
10 | METABOLIC AGENT | 85411 | 0% | 100% | 2 | Search METABOLIC+AGENT | Search METABOLIC+AGENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ONAY-BESIKCI, A , OZKAN, SA , (2008) TRIMETAZIDINE REVISITED: A COMPREHENSIVE REVIEW OF THE PHARMACOLOGICAL EFFECTS AND ANALYTICAL TECHNIQUES FOR THE DETERMINATION OF TRIMETAZIDINE.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 2. P. 147-165 | 130 | 89% | 16 |
2 | TSIOUFIS, K , ANDRIKOPOULOS, G , MANOLIS, A , (2015) TRIMETAZIDINE AND CARDIOPROTECTION: FACTS AND PERSPECTIVES.ANGIOLOGY. VOL. 66. ISSUE 3. P. 204 -210 | 47 | 84% | 8 |
3 | MARZILLI, M , (2003) CARDIOPROTECTIVE EFFECTS OF TRIMETAZIDINE: A REVIEW.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 19. ISSUE 7. P. 661-672 | 54 | 96% | 29 |
4 | FRAGASSO, G , ROSANO, G , BAEK, SH , SISAKIAN, H , DI NAPOLI, P , ALBERTI, L , CALORI, G , KANG, SM , SAHAKYAN, L , SANOSYAN, A , ET AL (2013) EFFECT OF PARTIAL FATTY ACID OXIDATION INHIBITION WITH TRIMETAZIDINE ON MORTALITY AND MORBIDITY IN HEART FAILURE: RESULTS FROM AN INTERNATIONAL MULTICENTRE RETROSPECTIVE COHORT STUDY.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 163. ISSUE 3. P. 320-325 | 32 | 82% | 20 |
5 | CHRUSCIEL, P , RYSZ, J , BANACH, M , (2014) DEFINING THE ROLE OF TRIMETAZIDINE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS: SOME INSIGHTS ON ITS ROLE IN HEART FAILURE AND PERIPHERAL ARTERY DISEASE.DRUGS. VOL. 74. ISSUE 9. P. 971 -980 | 40 | 66% | 5 |
6 | ELISEEV, OM , (1996) TROMETASIDIN (PREDUKTAL). A NEW APPROACH TO FIGHTING MYOCARDIAL ISCHEMIA.TERAPEVTICHESKII ARKHIV. VOL. 68. ISSUE 8. P. 57 -63 | 42 | 100% | 8 |
7 | GUARINI, G , HUQI, A , MORRONE, D , MARZILLI, M , (2016) PHARMACOLOGICAL AGENTS TARGETING MYOCARDIAL METABOLISM FOR THE MANAGEMENT OF CHRONIC STABLE ANGINA : AN UPDATE.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 30. ISSUE 4. P. 379 -391 | 51 | 44% | 0 |
8 | DEZSI, CA , (2016) TRIMETAZIDINE IN PRACTICE: REVIEW OF THE CLINICAL AND EXPERIMENTAL EVIDENCE.AMERICAN JOURNAL OF THERAPEUTICS. VOL. 23. ISSUE 3. P. E871 -E879 | 27 | 82% | 0 |
9 | ZHOU, X , CHEN, JC , (2014) IS TREATMENT WITH TRIMETAZIDINE BENEFICIAL IN PATIENTS WITH CHRONIC HEART FAILURE?.PLOS ONE. VOL. 9. ISSUE 5. P. - | 23 | 88% | 12 |
10 | MCCLELLAN, KJ , PLOSKER, GL , (1999) TRIMETAZIDINE - A REVIEW OF ITS USE IN STABLE ANGINA PECTORIS AND OTHER CORONARY CONDITIONS.DRUGS. VOL. 58. ISSUE 1. P. 143 -157 | 36 | 86% | 50 |
Classes with closest relation at Level 1 |